- Home
- CLH vs ICLR Comparison
CLH vs ICLR Comparison
Compare CLH & ICLR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | CLH | ICLR |
|---|---|---|
| Founded | 1980 | 1990 |
| Country | United States | Ireland |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 11.0B | 14.3B |
| IPO Year | 1987 | 1998 |
Fundamental Metrics
Financial Performance| Metric | CLH | ICLR |
|---|---|---|
| Price | $237.03 | $185.83 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 14 |
| Target Price | ★ $252.45 | $201.23 |
| AVG Volume (30 Days) | 622.3K | ★ 1.0M |
| Earning Date | 10-29-2025 | 10-22-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | 7.20 | ★ 7.47 |
| Revenue | $5,962,257,000.00 | ★ $8,102,602,000.00 |
| Revenue This Year | $2.95 | N/A |
| Revenue Next Year | $4.16 | $0.76 |
| P/E Ratio | $32.97 | ★ $24.87 |
| Revenue Growth | ★ 2.85 | N/A |
| 52 Week Low | $178.29 | $125.10 |
| 52 Week High | $255.44 | $228.29 |
Technical Indicators
Market Signals| Indicator | CLH | ICLR |
|---|---|---|
| Relative Strength Index (RSI) | 64.98 | 62.18 |
| Support Level | $213.85 | $174.13 |
| Resistance Level | $242.18 | $191.15 |
| Average True Range (ATR) | 6.56 | 8.46 |
| MACD | 3.53 | 2.87 |
| Stochastic Oscillator | 88.43 | 85.77 |
Price Performance
Historical ComparisonAbout CLH Clean Harbors Inc.
Clean Harbors Inc is an environmental and industrial services provider. It provides parts cleaning and related environmental services to commercial, industrial, and automotive customers. Its business segments are Environmental Services and Safety-Kleen Sustainability Solutions. The company generates the majority of its revenues from the Environmental Services segment.
About ICLR ICON plc
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical-device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.